List Title | APhA DrugInfoLine

Focus on Diabetes Care

SORT BY: Most Recent Most Viewed

July 28, 2015

Once-weekly dulaglutide beats out insulin glargine in type 2 diabetes

READ

PREVIEW
Individuals with type 2 diabetes who were taking prandial lispro (Humalog—Eli Lilly) in combination with once-weekly dulaglutide (Trulicity—Eli Lilly) achieved better glycemic control than those...
July 28, 2015

Serious drug interactions increase with use of multiple guidelines

READ

PREVIEW
Serious drug interactions may occur if medications recommended by evidence-based guidelines to manage varying chronic conditions are used concurrently, according to a systematic review of 12...
June 3, 2015

Alogliptin: No link with increased heart failure events

READ

PREVIEW
The use of alogliptin (Nesina—Takeda) in patients with type 2 diabetes and a recent acute coronary syndrome (ACS) event was not associated with an increased risk of heart failure–related...
March 24, 2015

Metformin: Expanding use in patients with kidney disease

READ

PREVIEW
Drug levels of metformin remain within the therapeutic range in patients with mild to moderate chronic kidney disease (CKD), and the occurrence of lactic acidosis with this agent is low,...
February 17, 2015

First-ever obesity drug treatment guidelines released

READ

PREVIEW
Appropriate use of FDA-approved weight loss medications and selection of medications to manage comorbid conditions that do not result in weight gain are among some of the topics covered in new...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.